Key PointsThe CFO of GeneDx reported selling 3,729 Class A shares for a total transaction value of $226,596.87 on June 16, 2026.The sale represented 8.54% of Feeley's direct Class A common stock holdings, reducing his direct Class A position from 43,683 to 39,954 shares.This transaction stemmed from the exercise of 7,197 options, with the shares sold directly and no indirect or third-party entity involvement.10 stocks we like better than GeneDx …